Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Staphylococcus Aureus Vaccine Safety in Healthy Adults
NCT02820883Phase 1Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Jun 2016
- Primary completion
- Aug 2016
- Countries
- 1
01
Overview
Phase 1, open-label trial in Staphylococcus aureus infection, sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Jun 2016; status: completed.
02
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT02820883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02820883.